成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

AT 1001

AT 1001 Struktur
1314801-63-2
CAS-Nr.
1314801-63-2
Englisch Name:
AT 1001
Synonyma:
AT 1001;(3-endo)-N-(2-Bromophenyl)-9-methyl-9-azabicyclo[3.3.1]nonan-3-amine;9-Azabicyclo[3.3.1]nonan-3-amine, N-(2-bromophenyl)-9-methyl-, (3-endo)-;(3-endo)-N-(2-Bromophenyl)-9-methyl-9-azabicyclo[3.3.1]nonan-3-amine , AT-1001
CBNumber:
CB33146256
Summenformel:
C15H21BrN2
Molgewicht:
309.25
MOL-Datei:
1314801-63-2.mol

AT 1001 Eigenschaften

Siedepunkt:
395.6±37.0 °C(Predicted)
Dichte
1.327±0.06 g/cm3(Predicted)
pka
10.96±0.40(Predicted)

Sicherheit

AT 1001 Chemische Eigenschaften,Einsatz,Produktion Methoden

AT 1001 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


AT 1001 Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Global( 10)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Nanjing Bicbiotechnology Co., Ltd
+86-2552131256 +86-18251840740
sales@bicbiotech.com China 5994 58
TargetMol Chemicals Inc.
+8613564774135
zijue.cai@tsbiochem.com United States 19885 58
Shanghai EFE Biological Technology Co., Ltd. 021-65675885 18964387627
info@efebio.com China 9806 58
Tianjin Kailiqi Biotechnology Co., Ltd. 15076683720
klq@cw-bio.com China 5931 55
BOC Sciences --
info@bocsci.com USA 0 65
Changzhou Furuisi Biotechnology Co., Ltd 0519-85524369
3477467573@qq.com China 8617 58
Bide Pharmatech Ltd. 400-1647117 13681763483
product02@bidepharm.com China 62075 58
TargetMol Chemicals Inc. 4008200310
marketing@tsbiochem.com China 24644 58
Nanjing Bic Biotechnology Co., Ltd 025-58906079 17352406906
sales@bicbiotech.com China 7852 58
Changzhou Yourui Pharmaceutical Technology Co., Ltd 18168818882 18168818882
877458914@qq.com China 1990 58

  • AT 1001
  • 9-Azabicyclo[3.3.1]nonan-3-amine, N-(2-bromophenyl)-9-methyl-, (3-endo)-
  • (3-endo)-N-(2-Bromophenyl)-9-methyl-9-azabicyclo[3.3.1]nonan-3-amine
  • (3-endo)-N-(2-Bromophenyl)-9-methyl-9-azabicyclo[3.3.1]nonan-3-amine , AT-1001
  • 1314801-63-2
Copyright 2019 ? ChemicalBook. All rights reserved